Mercy Medical Center has made history as the first hospital in the world to use the newly FDA-approved MarginProbe® 2 during breast-conserving surgery. This technology helps surgeons check tissue during surgery to make sure all cancer is removed. The device confirms whether the edges of the removed tissue are free of cancer, meaning that fewer patients have to return for another surgery, which can ease their stress and speed their recovery. Mercy has used the original MarginProbe since 2014 and